MedPath
NMPA Approval

Tafluprost Eye Drops

国药准字H20253164

January 14, 2025

Drug Information

他氟前列素滴眼液

眼用制剂

0.0015%(0.3ml:4.5μg)

化学药品

January 14, 2025

Company Information

Applicant Company

中国(辽宁)自由贸易试验区沈阳片区新运河路25号

Manufacturing Company

沈阳市浑南区泗水街68号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

他氟前列素滴眼液 - NMPA 批准文号 | MedPath